Back to Search
ERIK RIVERA, M.D.
M.D.
Internal Medicine Physician
NPI: 1891924866Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
D81294(MD)
Research & Publications (20)
Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma.
PMID 16909414·Cancer·2006
3-trial
Pilot study evaluating the pharmacokinetics, pharmacodynamics, and safety of the combination of exemestane and tamoxifen.
PMID 15041710·Clin Cancer Res·2004
3-trial
First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation study.
PMID 12927041·Breast Cancer Res·2003
4-observational
Current status of liposomal anthracycline therapy in metastatic breast cancer.
PMID 14667278·Clin Breast Cancer·2003
6-review
Liposomal anthracyclines in metastatic breast cancer: clinical update.
PMID 13679590·Oncologist·2003
6-review
Targeted filgrastim support in patients with early-stage breast carcinoma: toward the implementation of a risk model.
PMID 12872339·Cancer·2003
4-observational
Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer.
PMID 12947059·J Clin Oncol·2003
3-trial
Lack of activity of stealth liposomal doxorubicin in the treatment of patients with anthracycline-resistant breast cancer.
PMID 11914909·Cancer Chemother Pharmacol·2002
8-other
Phase I study of eniluracil and oral 5-fluorouracil in combination with docetaxel in the treatment of patients with metastatic breast carcinoma.
PMID 12015755·Cancer·2002
3-trial
Multicenter phase II study of a 28-day regimen of orally administered eniluracil and fluorouracil in the treatment of patients with anthracycline- and taxane-resistant advanced breast cancer.
PMID 11844821·J Clin Oncol·2002
3-trial
Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer.
PMID 11251001·J Clin Oncol·2001
3-trial
Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy.
PMID 11147589·Cancer·2000
3-trial
Management of metastatic breast cancer: monotherapy options for patients resistant to anthracyclines and taxanes.
PMID 19675449·Am J Clin Oncol·2010
6-review
Aminoguanidine impedes human pancreatic tumor growth and metastasis development in nude mice.
PMID 19266598·World J Gastroenterol·2009
7-preclinical
A comparison of experimental aneurysm occlusion determination by angiography, scanning electron microscopy, MICROFIL perfusion, and histology.
PMID 19582862·J Biomed Mater Res B Appl Biomater·2009
4-observational
Involvement of hydrogen peroxide in histamine-induced modulation of WM35 human malignant melanoma cell proliferation.
PMID 19285550·Free Radic Biol Med·2009
8-other
Nitrosyl hydride (HNO) as an O2 analogue: long-lived HNO adducts of ferrous globins.
PMID 19368336·Biochemistry·2009
7-preclinical
Sequence and crowding effects in the aggregation of a 10-residue fragment derived from islet amyloid polypeptide.
PMID 19486677·Biophys J·2009
7-preclinical
Effect of histamine on the expression of metalloproteinases and cell adhesion in breast cancer cell lines.
PMID 19274436·Inflamm Res·2009
8-other
Implementation of different initiatives to develop a culture of professionalism in the medical school.
PMID 19530555·P R Health Sci J·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 13975 CONNECTICUT AVE, SUITE 250
SILVER SPRING, MD 20906 - Phone
- (301) 557-1950
Quick Facts
- NPI
- 1891924866
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile